Trials / Completed
CompletedNCT05587764
Tempus Pro Monitor Registry
A Post Market Clinical Follow-up Study to Evaluate the Safety and Clinical Performance of the Tempus Pro, a Multi-parameter Vital Signs Monitoring Device With Specific Reference to ECG Recordings and Data Transmission Using Telemedicine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 103 (actual)
- Sponsor
- Philips Clinical & Medical Affairs Global · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A multicenter, prospective and retrospective, observational, post market study.
Detailed description
This observational study is to collect real-world data on the safety and performance of the Tempus Pro device, its accessories and the IntelliSpace Corsium telemedicine software device when used according to its intended purpose and the instructions for use, when used for patient monitoring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Standard of Care | Standard of care for emergency events per local guidelines. |
Timeline
- Start date
- 2024-04-25
- Primary completion
- 2024-08-12
- Completion
- 2024-08-12
- First posted
- 2022-10-20
- Last updated
- 2025-03-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05587764. Inclusion in this directory is not an endorsement.